ID: h-d3412634
Hypothesis
TET Enzyme Enhancement to Prevent Aberrant DNA Methylation
TET Enzyme Enhancement to Prevent Aberrant DNA Methylation.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 4 support✗ 4 oppose
🧪 Overview
TET Enzyme Enhancement to Prevent Aberrant DNA Methylation
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["TET1/TET2/TET3<br/>DNA Demethylase丰度"]
B["5mC to 5hmC<br/>Conversion Active"]
C["Aberrant DNA Methylation<br/>Prevention and Reversal"]
D["Neuronal Identity Genes<br/>Expression Restored"]
E["Epigenetic Age<br/>Rejuvenation"]
F["Neurodegeneration<br/>Progression Slowed"]
G["TET Enhancement<br/>as Epigenetic Therapy"]
A --> B
B --> C
C --> D
D --> E
E --> F
G -.->|"promotes"| A
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix4 supports4 contradicts
Supports
TET2 deficiency accelerates DNA methylation age in hematopoietic cells and correlates with neurodegenerative phenotypes
Supports
Vitamin C (ascorbate) acts as a cofactor for TET enzymes and enhances 5hmC generation in neurons
Supports
TET1 overexpression in mouse models improves cognitive function and reduces neuroinflammation
Contradicts
No direct TET activator exists - ascorbic acid supplementation is imprecise and requires doses causing adverse effects
Contradicts
Ascorbic acid supplementation in clinical trials (NCT02037919) failed to show cognitive benefit
Contradicts
Blood-brain barrier transport of ascorbic acid is saturable, limiting CNS delivery
Contradicts
TET enzymes have non-demethylation chromatin remodeling functions that could be affected by global enhancement
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TET1
No curated PDB or AlphaFold mapping for TET1 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TET1/TET2/TET3 enzymes from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TET1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↗
Rising
7d Momentum
▲ 1.4%
Volatility
Low
0.0105
Events (7d)
3
Price History
▲30.4%💾 Resource Usage
LLM Tokens
34,738
$0.1042
Total Cost
$0.1042
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF amyloid-positive older adults (age 65-85) are stratified into high vs. low peripheral blood mononuclear cell TET2 activity quartiles and followed longitudinally, THEN the low TET2 activity quartile | Faster cognitive decline measured by ADAS-Cog12 score trajectory; higher rate of conversion from MCI to probable AD dementia | — no observation — | pending | 0.55 |
| IF TET2 expression is genetically enhanced via CRISPR activation in human iPSC-derived cortical neurons exposed to oxidative stress (modeling neurodegeneration), THEN 5-hydroxymethylcytosine (5hmC) le | Increased 5hmC/5mC ratio at target gene promoters; reduced DNA methylation burden at neuroprotective genes | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF TET2 expression is genetically enhanced via CRISPR activation in human iPSC-derived cortical neurons exposed to oxidative stress (modeling neurodegeneration), THEN 5-hydroxymethylcytosine (5hmC) levels at promoter regions of neurodegeneration-associated genes will increase by >25% relative to scr
Predicted outcome: Increased 5hmC/5mC ratio at target gene promoters; reduced DNA methylation burden at neuroprotective genes
Falsification: No significant change in 5hmC levels (<10% increase) or no difference in methylation patterns between TET2-enhanced and control neurons, indicating TET2 enhancement is insufficient to alter methylatio
pendingconf 55%
IF amyloid-positive older adults (age 65-85) are stratified into high vs. low peripheral blood mononuclear cell TET2 activity quartiles and followed longitudinally, THEN the low TET2 activity quartile will exhibit 40% faster annual decline on the Alzheimer Disease Assessment Scale-Cognitive (ADAS-Co
Predicted outcome: Faster cognitive decline measured by ADAS-Cog12 score trajectory; higher rate of conversion from MCI to probable AD dementia
Falsification: No significant difference in cognitive decline rates between TET2 activity quartiles (hazard ratio <1.2 or p>0.05), or higher TET2 activity associated with worse outcomes, indicating peripheral TET2 a
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.